MYGN FY 2018 Earnings — Myriad Genetics, Inc. Revenue & Financial Results | Market Cap Arena

MYGNMyriad Genetics, Inc.

$454M

FY 2018 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$851M+10.2% YoY

Gross Profit

$650M76.4% margin

Operating Income

$8M0.9% margin

Net Income

$5M0.5% margin

EPS (Diluted)

$0.06

Cash Flow

Operating Cash Flow

$84M

Free Cash Flow

$75M

Stock-Based Comp.

$34M

Balance Sheet

Total Assets

$1.6B

Total Liabilities

$474M

Stockholders' Equity

$1.1B

Cash & Equivalents

$93M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$851M	$773M	+10.2%
Gross Profit	$650M	$595M	+9.2%
Operating Income	$8M	$119M	-93.6%
Net Income	$5M	$131M	-96.5%